Venture Capital · Profile from Venture Capital Research Companion
General Catalyst
A Cambridge, Massachusetts firm founded by two entrepreneurs that grew from a regional early-stage fund into a global, multi-strategy "investment and transformation" company, combining seed-to-growth venture capital with company creation, non-equity financing, a health-system acquisition and public-market deals, under the "responsible innovation" banner of CEO Hemant Taneja.
At a glance
- Founded
- 2000, Cambridge, Massachusetts
- Founders
- Joel Cutler and David Fialkow (both serial entrepreneurs)
- Headquarters
- Cambridge, MA and San Francisco; offices in New York, London, Berlin, Bengaluru and others
- Ownership / structure
- Private partnership; multi-strategy manager with venture funds, separately managed accounts and operating vehicles (e.g., HATCo)
- Leadership (2026)
- Hemant Taneja, CEO and managing director (CEO since 2021); Kenneth Chenault, chairman and managing director (joined 2018, ex-American Express CEO); Jeannette zu Fürstenberg, president / head of Europe (verify title); co-founder Joel Cutler, managing director
- AUM / capital raised
- ~$14.75bn raised in its first ~20 years (to 2022); ~$8bn new capital in 2024; AUM reported at ~$40bn+ (2024–2025)
- Stage focus
- Seed through growth (Ignition, Endurance), company creation (Creation), healthcare (Health Assurance), defence and resilience, non-dilutive (Customer Value Fund), control transactions
- Signature investments
- Kayak, HubSpot, Stripe, Snap, Airbnb, Gusto, Livongo, Grammarly, Samsara, Anduril, Helsing, Mistral AI, Commure, Summa Health (acquisition); failures/misses: Olive AI, Teladoc after the Livongo merger, written-down 2021-vintage fintech and digital-health holdings (see section 10)
10 deals and moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
2004
Kayak
Founding Series A / Incubation
2007
HubSpot
Series A
2012
Stripe
Series B
2013
Snap
Series B
2014
Gusto
Series A
2014
Livongo
Incubation and Founding Investment
2017
Grammarly
First Institutional Round
2020
Olive
Growth Rounds
2023
Mistral AI
Series A Participation and Series B Lead
2024
Summa Health
Acquisition via HATCo